Nuclear Medicine in Belgium

14 – 15 Oct 2026 | Suarlée, Belgium

HomeAgendaParticipantsMarketplace
Register
Register
Register

14 October 2026 - 15 October 2026

5020 Suarlée, Belgium

Business Village Ecolys Avenue d’Ecolys, 2

Nuclear Medicine in Belgium

Registration open until 9 Oct 2026

Why attend this international event? 

Belgium stands out as one of the most advanced and integrated hubs for nuclear medicine in Europe, boasting a comprehensive value chain that spans from research and development to patient delivery.

Participating in Nuclear Medicine in Belgium provides a rare opportunity to strategically engage with key stakeholders and foster high-value international collaborations.

Scheduled strategically just before the European Association of Nuclear Medicine (EANM) Global Annual Congress, this initiative promises an exceptional immersive experience featuring:

A Two-Day Immersive Program: Engage in a dynamic agenda that combines insightful industrial site visits with strategic discussions.

Direct Access to Senior Decision-Makers: Network with influential leaders across the entire nuclear medicine value chain.

Expert Insights: Benefit from keynote testimonials and presentations by Key Opinion Leaders (KOLs) on the latest industry trends and advancements.

Targeted B2B Meetings: Participate in exclusive networking opportunities designed to facilitate valuable connections and collaborations.

Join us to unlock the full potential of nuclear medicine in Belgium and elevate your international partnerships!

 DAY 1 - October 14

A rare opportunity to access critical infrastructure shaping the future of advanced radiopharmaceuticals:

Full Life Technologies Europe (Gembloux) - A brand-new state-of-the-art facility dedicated to the production and processing of actinium-225 — a cornerstone for the next generation of targeted alpha therapies.

Telix Pharmaceuticals (Seneffe) 

A global radiopharmaceutical company focused on  precision oncology. It's Seneffe site serves as a major european production and Innovation hub.

IRE – Institute for Radioelements (Fleurus) - A global leader in medical isotope production. A unique opportunity to discover their newly acquired IBA cyclotron strengthening Germanium-68 production, along with their new CDMO capabilities.

DAY 2 - October 15

High-Level Seminar & Strategic Discussions

Access one of the world’s most integrated nuclear medicine ecosystems in a single day — and identify concrete entry points for collaboration.

This high-level seminar brings together industry leaders, clinicians, researchers, regulators, clusters, and public authorities to discuss the latest trends and strategic developments in the field of nuclear medicine.

Strategic focus areas:

Innovation & Scale-Up – Through business case presentations and roundtables with C-level leaders, participants will explore how innovations move from R&D to clinical translation and industrial deployment in nuclear medicine.

Talent & Awareness– Experts will discuss practical strategies to close the talent gap and strengthen the global visibility and attractiveness of the nuclear medicine field.


Regulation & Market Access 
– Industry leaders and regulators will exchange perspectives to streamline regulatory pathways and accelerate international market access for innovative solutions.


Ecosystem Power 
– Discover how coordinated clusters and partnerships will transform regional excellence into European leadership with global impact.

It's time to

15

Sessions